ArticleClinical pharmacology and therapeutics2019

A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab-Treated non-small Cell Lung Cancer Patients.

Ida Netterberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.